Literature DB >> 40773

Metabolic fate of phenobarbital in man. N-Glucoside formation.

B K Tang, W Kalow, A A Grey.   

Abstract

1-(beta-D-Glucopyranosyl)phenobarbital was identified as the major metabolite of phenobarbital in man. Proof of structure was based on the comparison of the UV, NMR, and mass spectrometry and TLC data for the acetylated metabolite with an authentic compound. The previous erroneous structure assignment of this metabolite as N-hydroxyphenobarbital was based on insufficient data. After oral administration of 14C-labeled phenobarbital to two healthy male subjects, most of the radioactivity (87 and 78% of the dose) was recovered in urine over a period of 16 days. The N-glucopyranoside, p-hydroxyphenobarbital, and unchanged phenobarbital accounted for 30 and 24%, 18 and 19%, and 33 and 25% of the dose, respectively.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 40773

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

Review 1.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

2.  Disposition of hexobarbitone in healthy man: kinetics of parent drug and metabolites following oral administration.

Authors:  N P Vermeulen; C T Rietveld; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

3.  Identification of the diastereomers of pentobarbital N-glucosides excreted in human urine.

Authors:  W H Soine; P J Soine; T M England; R M Graham; G Capps
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

Review 4.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

5.  N1-glucosides as urinary metabolites of sulphadimidine, sulphamerazine and sulphamethoxazole.

Authors:  B Ahmad; J W Powell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jul-Sep       Impact factor: 2.441

6.  Stereochemical characterization of the diastereomers of the phenobarbital N-beta-D-glucose conjugate excreted in human urine.

Authors:  W H Soine; P J Soine; S E Mongrain; T M England
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

7.  Inhibition of phenobarbitone N-glucosidation by valproate.

Authors:  I Bernus; R G Dickinson; W D Hooper; M J Eadie
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

Review 8.  Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance.

Authors:  M J Eadie
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

9.  A novel metabolic pathway of morphine: formation of morphine glucosides in cancer patients.

Authors:  X Y Chen; L M Zhao; D F Zhong
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

10.  Stability of phenobarbital N-glucosides: identification of hydrolysis products and kinetics of decomposition.

Authors:  F B Vest; W H Soine; R B Westkaemper; P J Soine
Journal:  Pharm Res       Date:  1989-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.